European Journal of Dermatology
MENUThe COVID-19 pandemic: implications for patients undergoing immunomodulating or immunosuppressive treatments in dermatology Volume 30, numéro 6, November-December 2020
Auteurs
1 Department of Dermatology and Allergy, University Hospital, LMU Munich, Frauenlobstr. 9-11, 80337 Munich, Germany
2 Department of Dermatology, Universitätsklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany
- DOI : 10.1684/ejd.2020.3775
- Page(s) : 757-8
- Année de parution : 2020
The spectrum of dermatologic conditions is astonishingly broad and comprises, among others, neoplasms, drug reactions, autoimmune disorders and infections. Consequently, an enormous variety of therapeutic options for skin diseases exists. Immunomodulatory or immunosuppressive agents are prescribed to many patients and biologicals are applied to specifically target signalling pathways and key molecules of innate and adaptive immunity. The exact implications of these treatments and the susceptibility [...]